NR2F1 and endometrial cancer: Huang et al.’s (2018) study showed lncRNA NR2F1-AS1 regulates hepatocellular carcinoma oxaliplatin resistance via miR-363. Wang, Zhao & Mingxin (2019) recent study showed that lncRNA NR2F1-AS1 is involved in the progression of endometrial cancer.